NCT05939310View on ClinicalTrials.gov

Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

December 30, 2024

Conditions
Breast CancerBreast Cancer Invasive
Interventions
PROCEDURE

Fluorescence guided detection of tumor positive margins.

Intraoperative fluorescence imaging detection of tumor positive margins using the targeted tracer bevacizumab-IRDye800CW.

Trial Locations (2)

9713GZ

RECRUITING

University Medical Center Groningen, Groningen

9728NT

RECRUITING

Martini Ziekenhuis, Groningen

All Listed Sponsors
collaborator

Martini Hospital Groningen

OTHER

lead

University Medical Center Groningen

OTHER

NCT05939310 - Fluorescence Guided Surgery in Breast Cancer - The MARGIN-2 Study | Biotech Hunter | Biotech Hunter